Status:
RECRUITING
REDUCE LAP-HF III Corvia Protocol 1701
Lead Sponsor:
Corvia Medical
Conditions:
Heart Failure
Eligibility:
All Genders
40+ years
Brief Summary
This is a post market trial to be conducted at sites in Germany. The device has CE approval in the EU. The purpose of this observational registry is to collect post market data in consecutive patients...
Eligibility Criteria
Inclusion
- This is a post market registry so no criteria requirements (only recommendations).
Exclusion
Key Trial Info
Start Date :
July 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2028
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03191656
Start Date
July 12 2017
End Date
July 31 2028
Last Update
February 8 2024
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Herzzentrum der Kerckhoff-Klinik
Bad Nauheim, Germany
2
Herz- und Diabeteszentrum Nordrhein-Westfalen Klinik für Kardiologie
Bad Oeynhausen, Germany
3
Segeberger Kliniken GmbH
Bad Segeberg, Germany
4
Unfallkrankenhaus Berlin
Berlin, Germany